PubMed Health⌕ Search

Biomedical subjects

J M Mallion

Publications and source records attributed to J M Mallion.

At least 19 recordsLinked to original sources
PubMed1992

Comparison of angiotensin-converting enzyme inhibitors and calcium antagonists in the treatment of mild to moderate systemic hypertension, according to baseline ambulatory blood pressure level.

This study was aimed at determining whether baseline ambulatory blood pressure (BP) levels influence the efficacy of angiotensin-converting enzyme inhibitors and calcium antagonists in the same manner. Accordingly, the ambulatory BP recordings of 236 mild to moderate hypertensive patients who had previously entered a clinical trial and had received either a calcium antagonist (n = 121) or an angiotensin-converting enzyme inhibitor (n = 115) were reviewed. The inclusion criterion was a clinic diastolic BP between 95 and 115 mm Hg at the end of the placebo period. Patients were classified according to the difference between their observed and predicted ambulatory BP (the latter assessed by regressing the observed ambulatory BP on the clinic BP). Reduction in ambulatory systolic and diastolic BP seemed to be greater (p less than 0.0001, p = 0.01) in patients receiving an angiotensin-converting enzyme inhibitor than in those who were given a calcium antagonist. However, analysis of variance showed (1) there was a significant interaction (F = 6.37 p = 0.01) between the pharmacologic class and the baseline systolic ambulatory BP; and (2) the difference in diastolic ambulatory BP reduction between both classes was no longer significant when adjusted for baseline diastolic ambulatory BP. In patients with higher than predicted ambulatory BP levels, angiotensin-converting enzyme inhibitors and calcium antagonists had roughly a similar effect (reduction in systolic BP, 9 +/- 8% vs 7 +/- 6%, p = not significant; reduction in diastolic BP, 11 +/- 8% vs 8 +/- 6%, p = not significant).(ABSTRACT TRUNCATED AT 250 WORDS)

Adult↗
PubMed1992

Use of a microprocessor-equipped tablet box in monitoring compliance with antihypertensive treatment.

Compliance with antihypertensive therapy is usually monitored by questionnaire, tablet counts, or estimation of drug levels in blood or in urine. The aim of this study was to examine patient compliance by means of an "electronic monitor." After 2 weeks of run-in on placebo, 34 moderately hypertensive patients were included in an open, randomized, crossover trial examining the efficacy and tolerance of nitrendipine, 20 mg as a single daily dose (morning or evening) for 1 month. We analyzed the results in 26 patients. Patients were supplied with tablet boxes equipped with a microprocessor (MENS) that registered the timing and duration of opening of the box over both the placebo and nitrendipine periods. Compliance (%) was calculated as the ratio of the number of days that the pill box was opened to the number of days between visits. The compliance was analyzed for each treatment group, namely placebo and nitrendipine morning and evening, over 1 month. Compliance (mean + SD) was 96.5 +/- 7.4% on placebo and 94.4 +/- 10.7% in the morning and 90.6 +/- 15.4% in the evening. Nitrendipine was taken in the morning at 0700 h +/- 2 h and in the evening at 1859 h +/- 2 h 12 min. The frequency of 24 h +/- 1 h intervals between medication was 83.5% on placebo. This frequency was 72.6% for morning dosage and 71.8% for evening dosage on nitrendipine. There were no differences in compliance between the morning and evening groups when analyzed according to age and sex. There was a negative correlation with time (r = -0.57, p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Blood Pressure↗
PubMed1992

Use of ambulatory blood pressure monitoring in the management of antihypertensive therapy.

The recent development of ambulatory blood pressure (ABP) monitoring techniques has improved recording of blood pressure in therapeutic trials and in the clinical setting. The application of ABP differs according to which of these 2 applications is being considered. In therapeutic trials, a placebo control is required. The large quantity of precise data acquired with ABP monitoring allows the study of a limited number of patients; it also allows individual study of patients with a 'white coat' response (i.e. elevated blood pressure in response to examination by the clinician). Analysis of data from ABP monitoring may include the following: comparison of mean blood pressure values over 24 hours, daytime or night-time, or over any other selected time period; 24-hour blood pressure profiles, or analysis hour-by-hour, giving true chronotherapy, and providing data regarding the wearing-off of a drug effect or loss of therapeutic control; analysis of blood pressure at particular times, such as on waking; or specific examination of nonresponders. In individual patients, ABP monitoring should be reserved for specific indications. It can be used before initiation of treatment to confirm the necessity for treatment, especially in the context of hypertension at rest or the 'white coat' effect. With established treatment, ABP monitoring can be used in patients with resistant hypertension, in severe hypertension to examine loss of blood pressure control over time or inversion of the day/night cycle, and in patients with a specific illness, e.g. diabetes, in order to obtain the lowest blood pressure readings possible. Examination of these factors assists clinicians to accurately decide upon the timing and frequency of antihypertensive therapy.

Blood Pressure Monitors↗
PubMed1992

Early disturbances of ambulatory blood pressure load in normotensive type I diabetic patients with microalbuminuria.

OBJECTIVE: To compare 24-h ABP in normotensive type 1 diabetic patients with and without microalbuminuria. RESEARCH DESIGN AND METHODS: The study was a retrospective comparison of cases and matched control subjects. The first phase included 35 type 1 diabetic patients, normotensive by OMS criteria. The 23 patients with normoalbuminuria (< 15 micrograms/min) were compared with 12 patients with microalbuminuria (> or = 15 micrograms/min). In the second phase, the 12 microalbuminuric patients were paired by sex- and age-matched with 12 normoalbuminuric patients and 12 nondiabetic healthy control subjects. We measured casual systolic and diastolic BP and HR, 24-h ABP and AHR (recorded with a Spacelabs automatic recorder), and microalbuminuria. RESULTS: No correlation between microalbuminuria and casual BP was observed. Microalbuminuria was correlated significantly with diastolic 24-h APR and nocturnal systolic and diastolic ABP (r = 0.35, 0.38, and 0.33, respectively; P < 0.05) and with AHR during all time periods (24-h, r = 0.46; day, r = 0.39; night, r = 0.39; P < 0.05). Normo- and microalbuminuric patients did not differ in casual BP and HR. However, microalbuminuric patients had a significant increase in systolic 24-h ABP (119.1 +/- 8.2 vs. 113.1 +/- 8.1, P = 0.05), diastolic 24-h ABP (74.9 +/- 7.5 vs. 70.2 +/- 5.7, P = 0.04), nocturnal systolic ABP (112.8 +/- 7.1 vs. 105.8 +/- 7.9, P = 0.01), and AHR during all time periods. The same results were observed when patients were paired by age and sex. CONCLUSIONS: Normotensive microalbuminuric type 1 patients, although strictly comparable with normoalbuminuric patients for casual BP and HR, have an increased ABP and HR, especially during the night. This difference might reflect dysautonomia. Ambulatory measurement of BP and HR is more appropriate than casual measurements in hemodynamic studies of incipient diabetic nephropathies and could be proposed as an interesting tool for an early prediction of diabetic nephropathy.

Adult↗
PubMed1992

Relationship between low-frequency oscillations of blood pressure and changes in arterial diameter.

AIM: To study spontaneous variations in radial artery compliance. METHODS: Compliance was evaluated non-invasively by an echo-tracking system, and variations in sympathovagal tone were analysed by a spectral analysis of continuous blood pressure recordings using a Fast Fourier algorithm. We studied 23 healthy volunteers, aged 25 +/- 4 years (mean +/- SD), at rest, on two occasions at least one day apart (5 +/- 3 days). RESULTS: There were no significant differences between the means of the arterial compliance measurements and those of the corresponding spectral analysis. However, the magnitude of change in the low-frequency periods (4-66 mHz) was significantly related (P less than 0.01) to a significant and inverse change in compliance for the same level of blood pressure. CONCLUSIONS: While it is possible to use spectral analysis to measure the effect of autonomic nervous regulation on radial artery properties, low-frequency periods cannot be safely ascribed to sympathetic effects alone. Other effects must also be taken into account in measurements of radial artery distensibility.

Adult↗
PubMed1992

[Evaluation of norepinephrine content in the myocardium in hypertensive patients with left ventricular hypertrophy].

The sympathetic nervous system seems to be a non hemodynamic factor involved in the development of hypertension and in left ventricular hypertrophy determinism. The aim of this study was to estimate the myocardial norepinephrine content in essential hypertensive patients, using a reliable radio-iodinated marker of norepinephrine: the 123I-meta-iodobenzylguanidine (123I-meta-iodobenzylguanidine). Eight male and female hypertensive patients with left ventricular hypertrophy and average age of 52 +/- 9 years underwent a resting, ambulatory and effort blood pressure measure. Echocardiographic parameters allowed measure of left ventricular mass index (according to Devereux, and we considered left ventricular hypertrophy as left ventricular mass index greater than 120g/m2. Plasma norepinephrine is measured at rest. Cardiac and mediastinal radioactivity is detected 4 h after a 4mCi i.v. injection of 123I-meta-iodobenzylguanidine and meta-iodobenzylguanidine myocardial uptake is definite as the cardiac/mediastinal ratio (N:1.78 +/- 0.19). Meta-iodobenzylguanidine-myocardial uptake average value of hypertensive patients was 1.89 +/- 0.19 (1.63 to 2.25) without statistical difference to control subjects. We found a significative correlation between meta-iodobenzylguanidine myocardial uptake and effort systolic blood pressure variation in one hand, and with heart rate increase with effort in the other hand. There is no correlation between meta-iodobenzylguanidine-myocardial uptake and left ventricular mass index or ambulatory blood pressure. In hypertensive patients with left ventricular hypertrophy, meta-iodobenzylguanidine myocardial uptake is normal or high, in agreement with experimental data in SHRs, model of human essential hypertension. Therefore myocardial scintigraphy with 123I-meta-iodobenzylguanidine can appreciate cardiac norepinephrine content in humans.

3-Iodobenzylguanidine↗
PubMed1992

[Action of labetalol on norepinephrine myocardial content in left ventricular hypertrophy in hypertensive patients].

The high incidence of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy shows the great interest in understanding the pathophysiology of this process. Many reports suggest the role of catecholamines in generating left ventricular hypertrophy. The aim of this study is to evaluate the effect of labetalol on myocardial norepinephrine content in hypertensive subjects with left ventricular hypertrophy by using an isotopic norepinephrine marker, the 123I-meta-iodobenzylguanidine (123I-MIBG). Eight male and female hypertensive patients with left ventricular hypertrophy were investigated after a 30 day placebo period. Resting, ambulatory and effort blood pressure was measured. Echocardiographic parameters allowed measure of left ventricular mass index according to Devereux. And we considered left ventricular hypertrophy as left ventricular mass index greater than 120 g/m2. Cardiac and mediastinal radioactivity is detected 4 h after a 4 mCi i.v. injection of 123I-MIBG and MIBG myocardial uptake is definite as the cardiac/mediastinal ratio (N : 1.78 +/- 0.19). All subjects received at the beginning of the study (D0) 2 tablets of labetalol 200 mg, increased to 4 tablets if diastolic blood pressure during follow-up remained above 95 mmHg. Patients again underwent these explorations after 3 months of treatment (D90). Labetalol decreases in considerable manner MIBG myocardial uptake as it has been shown that it decreases tissular norepinephrine content in experimental studies. Therefore, MIBG myocardial uptake seems to be a reliable tool in evaluating drugs effect on cardiac sympathetic nervous system.

3-Iodobenzylguanidine↗
PubMed1992

[Methods of computerized approach of dysautonomia from a non-invasive pressure signal].

OBJECTIVE: examination of an automated exploration of autonomic neuropathy using the Ewing score and evaluation of sympatho-vagal tone. MATERIAL: continuous non-invasive collection of blood pressure (BP) data by means of Finapress fingerprobe. The signal was analysed after digitization at 500Hz, sampled and computerised. Values of systolic BP (SBP), diastolic BP (DBP) and heart rate (HR) are analysed by Anapres (Notochord). PROTOCOL: the pressure monitor is placed on the finger and the reading calibrated to the BP value recorded by auscultatory method on the contralateral arm to give a gap of less than 10 mmHg. BP and HR response to five different manoeuvres are recorded, namely: at rest over 7 minutes, after lying decubitus for 15 minutes; on rising suddenly over 3 seconds, and then over 9 minutes standing still; during 2 respiratory manoeuvres (a) deep breathing over 6 cycles per minute, (b) Valsalva pressure at 40 mmHg sustained over 20 seconds; isometric exercise with sustained handgrip at 30% maximal force sustained over 3 minutes. ANALYSIS: a dedicated computer programme displays in graphic form BP and HR over each manoeuvre and allows the operator to locate the exact cut-off of normality for each test of the Ewing score and also measure the balance of sympatho-vagal tone by Fourier transformation of the interval data of HR or BP peaks. APPLICATION: this approach allows evaluation of autonomic function and sympatho-vagal tone by means of 40 minutes of clinical testing and two minutes of automated analysis. This approach seems useful in the assessment of the autonomic nervous system in diabetes.

Autonomic Nervous System Diseases↗
PubMed1992

[Efficacy of antihypertensive treatment in the French population. A multicenter survey].

In order to assess the efficacy of antihypertensive treatment in the population, a study was undertaken in 5 French cities during the commercial fairs of Grenoble, Marseilles, Nice, Toulouse and Lille. The blood pressure was measured according to the WHO recommendations in volunteers. The study included a total of 7107 subjects of both sexes, with 4064 subjects in the 35-64 year age group. The therapeutic efficacy was evaluated in the 791 hypertensive patients who knew their antihypertensive therapy. Taking < 160/95 mmHg as the criterion of efficacy, 52 to 73% of the hypertensive patients were well controlled. However, if the therapeutic objective of normalisation of the blood pressure (BP < 140/90 mmHg) is taken as the criterion of efficacy, only 23 to 29% of the hypertensive patients were controlled whilst their BP remained significantly higher than that of normotensive controls of the same age. The difference in efficacy of antihypertensive therapy between the cities may be explained by the heterogenicity of the populations whereas the treatment did not differ significantly. After adjustment analysis with respect to sex showed that women were better controlled than men whatever the criterion chosen. The group controlled at BP < 160/95 mmHg only differed from the group < 140/90 with respect to the average BP value which was higher before treatment and decreased less with treatment; though this did not achieve statistical significance. In matters of public health, if the ideal blood pressure is taken as < 140/90 mmHg, this study shows that the objective is only attained in one out of four patients in the population studied.

Adult↗
PubMed1992

[Hypertension associated with diabetes: inquiry into the attitudes and behaviors of French physicians].

In order to assess the prevalence of arterial hypertension, diabetes mellitus, and of the association of both diseases, and furthermore, to underline the behaviours and feelings of French physicians in front of these combined diseases, a survey has been undertaken by the SOFRES Medical institute and by Laboratoires Hoechst, which involved 304 physicians in private practice and 67 hospital doctors. After face-to-face interviews, each participant had to fill up a questionnaire dealing with his general feelings and attitudes, and then completed 2 case record forms (5 cases for hospital doctors) from their last patients who presented with hypertension and diabetes mellitus. All these informations have allowed us to describe their behaviours. The 304 physicians have been selected with a regional stratification by a random survey quota method that gave a valid sample from the French medical population: 213 general practitioners (GPs), 67 cardiologists, 24 endocrinologists have been involved in the survey. They have been able to observe 149 hypertensive insulin-dependent diabetic patients and 470 hypertensive non insulin-dependent diabetic patients (respectively 24% and 76%). In addition, 67 hospital doctors (32 cardiologists, 17 diabetologists, 18 nephrologists) have been involved and have filled 255 case record forms (120 insulin-dependent and 135 non insulin-dependent diabetic patients). The association between hypertension and diabetes mellitus is very common: 55% out of the diabetic patients treated by GPs presented with hypertension, 20% out of the hypertensive patients presented with diabetes mellitus. The discovery of hypertension is usually followed by the discovery of non insulin-dependent diabetes mellitus. The opposite feature is observed for the insulin-dependent diabetic patients. The majority of the doctors feels that the cardiovascular prognosis of the association is worse than each single disease. The level of blood pressure that is suitable to start an antihypertensive treatment in hypertensive insulin-dependent and non insulin-dependent diabetic patients is generally lower than for non diabetic hypertensive patients, especially for the diabetologists. Concerning antihypertensive treatments, discrepancies have been observed in between feelings and behaviours of physicians. The class of drug that is thought to be used is obviously different from the one which is really used: angiotensin-converting enzyme inhibitors and calcium antagonists, two rather new classes of drugs are popular while classical classes of antihypertensive agents like diuretics and betablockers are still commonly used. Non pharmacological interventions which are useful for both the treatment of hypertension and diabetes mellitus are not commonly recommended by GPs and specialists.

Cardiology↗
PubMed1991

[Study of the 24 hour blood pressure profile in normotensive type I diabetic patients].

A number of studies have shown changes and even an inversion of the diurnal cycle in certain affections: Cushing's syndrome, pheochromocytoma, severe renal failure, autonomous nervous system disorders, pre eclampsia etc.... The authors studied diurnal and nocturnal variations of blood pressure in type I diabetics. Twenty-nine normotensive (WHO criteria) type I diabetics (NTD) average age 34.9 +/- 11 years, with diabetes of 13.6 +/- 8 years standing, and 118 normotensive non-diabetics (NT) aged 20 to 60 years (distributed by decennies according to age and sex) were studied. The systolic (SBP) and diastolic blood pressures (DBP) were recorded at rest in the decubitus position by the phase V indirect auscultatory method and during ambulatory monitoring (automatic Spacelabs no. degrees 90207 device) every 15 minutes during the daytime and 20 minutes during the night. The mean values were studied; the values of the heart rates were identical in the NTD and NT populations. Significant difference in SBP between the Nt and NTD were recorded: during daytime there was no difference either in SBP or DPB; during the night, there was a significant difference in SBP. A study of the day-night differences both in absolute and in relative values (day-night difference with respect to daytime values as a percentage) did not show any statistically significant differences between the two populations. Abnormalities of the 24 hour profile, defined as absence of a 5 mmHg fall in nocturnal BP values, were looked for but there were no differences between the NT and NTD subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Adult↗
PubMed1991

[Role of ambulatory blood pressure measurement in the evaluation of the cardiovascular load in high altitude workers].

UNLABELLED: This study evaluates ambulatory blood pressure ABP measurement as a technique for measuring the cardiovascular load in maintenance mechanics working on mechanical lifts at altitudes of over 2,500 meters (stress due to altitude and intensive static and dynamic work). METHOD: 25 normotensive workers were studied during real working conditions. Each subject underwent a maximal stress test, and echocardiography. An ABP recording (Spacelab 90207) with BP measurement every 15 minutes and continuous heart rate (HR) monitoring (Essilor IFC85), during 24 hours were performed on the same day. ANALYSIS: study of BP levels and their factors of variation, comparison of this data with continuous HR measurements, and with results of the stress test and echocardiography. RESULTS: even in difficult conditions (while balancing on cables and cable towers), ABP measurements is possible (less than 10% missing values). Systolic (SBP) and diastolic (DBP) blood pressure and HR values adjusted for age are significantly higher during work activity (9:00-12:00, 14:00-15:00) in these subjects than in reference normotensive subjects. ABP did not differ significantly between different types of work while the equivalent mechanical load (work load that gives a stress test HR equal to the mean HR during work) reveals a different between work activities. At night SBP remains higher and HR values lower than in control subjects. In comparison with reference criteria, 3 subjects were considered as having an abnormally high ABP during the daytime. ABP results were not linked with number of years in the profession nor with the altitude at which the subject worked or lived. Although 40% of subjects have a left ventricular mass index greater than 135 g:m2, there is no link between ultrasound and ABP parameters. CONCLUSION: while ABP measurement seems possible in this type of professional activity, BP values do not appear to be correlated to work level measured. The absence of correlation with left ventricular mass, suggests that the process of cardiovascular adaptation is different from that in even moderately hypertensive subjects.

Adaptation, Physiological↗
PubMed1991

[Nyctohemeral changes of blood pressure. Diagnostic and prognostic value].

The blood pressure shows circadian variation in normal subjects with higher diurnal than nocturnal values: the difference between day and night time blood pressure is about 10-20 mmHg for systolic and for diastolic blood pressure. These variations are mainly related to physical and/or psychosensorial stress: the physician is himself a cause of increased blood pressure (the "white coat" effect). The degree of the nocturnal decrease in blood pressure which is maximal 2 and 3 o'clock is related to the quality and depth of sleep. The nocturnal decrease is followed by an increase in blood pressure when the person wakes up (early morning peak). Diagnostic signs: a physiological inversion of the circadian rhythm may be observed in people who sleep during the daytime and work at night. There would seem to be less of a nocturnal fall in black persons in the United States. Some pathological conditions can inverse or at least disturb the ciacadian variation: apart from hypertension, this has been reported in autonomic nervous system disease, in diabetics with autonomic neuropathy in some elderly patients, in Cushing's syndrome, after cardiac transplantation, etc... In hypertensives, the lack of nocturnal decrease of the blood pressure or an inversion in circadian rhythm should be looked for in severe and secondary hypertension such as associated with pheochromocytoma, or in renal dialysis patients. In toxaemia of pregnancy, this abnormality may herald an eclamptic crisis. Prognostic signs: in normotensives (especially in black persons) and hypertensives, inversion of the circadian rhythm is associated with more severe left ventricular hypertrophy and a higher morbidity.

Adult↗
PubMed1991

[Analysis of results of the determination of ambulatory blood pressure].

Although there has never been a consensus about the presentation and analysis of the results of ambulatory blood pressure recordings, it is important to define the stages and useful means both for studying individual and groups of recordings (therapeutic trials): individual recordings: edition of results, 24 hour display, quantification of the blood pressure over predefined periods, comparison with reference values; therapeutic trials: verification of the quality of the recordings (consecutive hours without measurements, artefacts), preparation of the results for analysis (grouped in hourly mean values), search for confusing factors and non-adherence to the protocol, analysis of efficacy over 24 hours and predefined periods, partial studies (non-responders, normalisation of blood pressure with respect to reference values, control of efficacy over more than 24 hours...). All these stages must be predefined in the study protocol.

Ambulatory Care↗
PubMed1990

Day and night blood pressure values in normotensive and essential hypertensive subjects assessed by twenty-four-hour ambulatory monitoring.

Circadian blood pressure variations were studied in 110 normotensive (blood pressure less than or equal to 140/90 mmHg) and 142 untreated essential hypertensive (blood pressure greater than or equal to 160/95 mmHg) subjects. Measurements were carried out under full ambulatory conditions by the oscillometric method, using an automatic device (SpaceLabs 5200). Readings taken between 9.00 a.m. and 7.00 p.m. were defined as daytime values (activity), and those taken between 11.00 p.m. and 7.00 a.m. as night-time values (sleep). Blood pressure was significantly higher during the day than at night. The day-night differences were significantly higher in the hypertensive than in the normotensive subjects. There was a significant correlation for both systolic blood pressure (SBP) and diastolic blood pressure (DBP) between the day-night differences and DBP values at rest. The difference between the normotensives and hypertensives was smaller when the day-night difference was calculated as a percentage of the daytime blood pressure, but the SBP difference remained significantly higher in the hypertensives. The number of subjects without a nocturnal blood pressure decrease or with a decrease of less than 5-10 mmHg was not statistically different between the normotensives and the hypertensives. These results are a contribution towards an understanding of day-night blood pressure differences in hypertensive and in normotensive subjects. A knowledge of the 24-h blood pressure profile in the individual patient is important because abnormal profiles may be linked with various etiologies responsible for dysregulation, and might have prognostic implications.

Adult↗